SG10201705388XA - A Method Of Improving Liver Function - Google Patents

A Method Of Improving Liver Function

Info

Publication number
SG10201705388XA
SG10201705388XA SG10201705388XA SG10201705388XA SG10201705388XA SG 10201705388X A SG10201705388X A SG 10201705388XA SG 10201705388X A SG10201705388X A SG 10201705388XA SG 10201705388X A SG10201705388X A SG 10201705388XA SG 10201705388X A SG10201705388X A SG 10201705388XA
Authority
SG
Singapore
Prior art keywords
liver function
improving liver
improving
function
liver
Prior art date
Application number
SG10201705388XA
Other languages
English (en)
Inventor
Ken Walder
Guy Krippner
Geoff Nicholson
Original Assignee
Verva Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verva Pharmaceuticals Ltd filed Critical Verva Pharmaceuticals Ltd
Publication of SG10201705388XA publication Critical patent/SG10201705388XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
SG10201705388XA 2012-05-24 2013-03-15 A Method Of Improving Liver Function SG10201705388XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261651335P 2012-05-24 2012-05-24
US201261666574P 2012-06-29 2012-06-29

Publications (1)

Publication Number Publication Date
SG10201705388XA true SG10201705388XA (en) 2017-07-28

Family

ID=49622927

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201705388XA SG10201705388XA (en) 2012-05-24 2013-03-15 A Method Of Improving Liver Function
SG11201407787VA SG11201407787VA (en) 2012-05-24 2013-03-15 A method of improving liver function

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201407787VA SG11201407787VA (en) 2012-05-24 2013-03-15 A method of improving liver function

Country Status (15)

Country Link
US (2) US20150150855A1 (ru)
EP (1) EP2854807A4 (ru)
JP (2) JP6360826B2 (ru)
KR (1) KR20150023405A (ru)
CN (2) CN104487073A (ru)
BR (1) BR112014029308A2 (ru)
CA (1) CA2874513A1 (ru)
CO (1) CO7160082A2 (ru)
HK (1) HK1209051A1 (ru)
MX (1) MX362111B (ru)
NZ (2) NZ723206A (ru)
RU (1) RU2653478C2 (ru)
SG (2) SG10201705388XA (ru)
WO (1) WO2013173859A1 (ru)
ZA (1) ZA201408704B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089521A1 (en) 2007-01-25 2008-07-31 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment
US20150174108A1 (en) * 2012-05-24 2015-06-25 Vera Pharmaceuticals Ltd Method of weight reduction
US10039752B2 (en) * 2016-07-21 2018-08-07 Cipla Limited Methazolamide for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783241A (en) * 1957-02-26 S-acylimino-x-substituted-az-i
DE10035227A1 (de) * 2000-07-20 2002-01-31 Solvay Pharm Gmbh Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
US7129220B2 (en) 2003-08-01 2006-10-31 Janssen Pharmaceutica N.V Substituted indole-O-glucosides
WO2008089521A1 (en) * 2007-01-25 2008-07-31 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment
US20150174108A1 (en) * 2012-05-24 2015-06-25 Vera Pharmaceuticals Ltd Method of weight reduction

Also Published As

Publication number Publication date
NZ702645A (en) 2016-08-26
EP2854807A1 (en) 2015-04-08
CO7160082A2 (es) 2015-01-15
CA2874513A1 (en) 2013-11-28
KR20150023405A (ko) 2015-03-05
EP2854807A4 (en) 2016-03-16
WO2013173859A1 (en) 2013-11-28
JP6360826B2 (ja) 2018-07-18
HK1209051A1 (en) 2016-03-24
BR112014029308A2 (pt) 2017-06-27
SG11201407787VA (en) 2014-12-30
NZ723206A (en) 2018-02-23
JP2015517534A (ja) 2015-06-22
RU2653478C2 (ru) 2018-05-08
ZA201408704B (en) 2018-07-25
CN109498623A (zh) 2019-03-22
CN104487073A (zh) 2015-04-01
JP6412241B2 (ja) 2018-10-24
US20150150855A1 (en) 2015-06-04
JP2018090589A (ja) 2018-06-14
MX2014014317A (es) 2015-08-10
RU2014152196A (ru) 2016-07-20
US20180333399A1 (en) 2018-11-22
MX362111B (es) 2019-01-07

Similar Documents

Publication Publication Date Title
GB2506203B (en) Method of interacting with a simulated object
GB201212937D0 (en) Method
GB201212932D0 (en) Method
GB2508977B (en) Method of forming a spoiler
GB201213636D0 (en) Method
GB201212934D0 (en) Method
GB201210858D0 (en) Method
PL2836154T3 (pl) Sposób montażu dystalizatora
EP2880048A4 (en) METHOD
GB201202198D0 (en) Method
HK1209051A1 (en) A method of improving liver function
HRP20181348T1 (hr) Postupak izrade panela
GB201211393D0 (en) Method
PL2662656T3 (pl) Sposób wykonania grzejnika
GB201215942D0 (en) Method of treatent
GB201217688D0 (en) Method
GB201214029D0 (en) method
GB201210147D0 (en) Method
EP2861069A4 (en) METHODS FOR IMPROVING HEPATIC FUNCTION
GB201213858D0 (en) Method
GB201203337D0 (en) Method
GB201201332D0 (en) Method
EP2639418A4 (en) EXHAUST HEATING METHOD
GB201216100D0 (en) A method of securing two mechanical parts
GB201212279D0 (en) Method of construction